Clinical Trials

1 2 3 186
Number of results: 3710

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2017-03-22 serelaxin - RLX030 acute heart failure 3 Novartis (Switzerland) Cardiovascular diseases
2017-02-24 V212 herpes zoster 3 Merck&Co (USA - NJ) Infectious diseases
2017-02-24 IMO-2125 in combination with ipilimumab or pebrolizumab patients with metastatic melanoma with disease that is refractory to PD-1 inhibitors. 1-2 Idera Pharmaceuticals (USA - CA) Cancer - Oncology
2017-02-23 Baremsis™ - APD421 (amisulpride - intravenous formulation of a currently marketed dopamine D2 antagonist for the new use of prevention and treatment of nausea & vomiting) post-operative nausea & vomiting (PONV) Acacia Pharma (UK) Gastrointestinal diseases - Digestive diseases
2017-02-23 Toca 511 & Toca FC glioblastoma multiforme, anaplastic astrocytoma 2-3 Tocagen (USA - CA) Cancer - Oncology
2017-02-21 MOR107 (formerly LP2) 1 Lanthio Pharma, Morphosys ' subsidiary (The Netherlands)
2017-02-21 emicizumab (ACE910 - anti-factor IXa x anti-factor X humanized bispecific antibody) hemophilia A 3 Roche (Switzerland) Rare diseases - Genetic diseases - Hematological diseases
2017-02-20 savolitinib pulmonary sarcomatoid carcinoma 2 Hutchison China MediTech Limited "ChiMed" (China) Cancer - Oncology
2017-02-19 Tecentriq® (atezolizumab) and Avastin® (bevacizumab) renal cell carcinoma 2 Roche (Switzerland) Cancer - Oncology
2017-02-18 NKTR-214 solid tumors including melanoma, renal cell carcinoma (RCC), bladder cancer, colorectal cancer 1-2 Nektar Therapeutics (USA - CA) Cancer - Oncology
2017-02-17 Entyvio® (vedolizumab) moderately to severely active ulcerative colitis, Crohn's disease 3 Takeda Pharmaceutical (Japan) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2017-02-17 Cx601 (adipose derived allogeneic stem cell therapy) perianal fistulas in Crohn's disease patients 3 Tigenix (Belgium) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2017-02-17 tivantinib (ARQ 197) hepatocellular carcinoma 3 ArQule (USA - MA) Daiichi Sankyo (Japon) Cancer - Oncology
2017-02-17 Lynparza™ (olaparib) HER2-negative metastatic breast cancer harbouring germline BRCA1 or BRCA2 mutations 3 AstraZeneca (UK) Cancer - Oncology
2017-02-17 ABO-102 (SC AAV-SGSH) mucopolysaccharidosis type IIIA (Sanfilippo B syndrome) 1-2 Abeona Therapeutics (USA - NY) Rare diseases - Genetic diseases
2017-02-17 CT-P13 - Inflectra®/Remsima® (biosimilar infliximab) Crohn's disease 3 Celltrion Healthcare (South Korea) Pfizer (USA - NY) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2017-02-17 ozanimod - RPC1063 multiple sclerosis 3 Celgene (USA - NJ) Autoimmune diseases - Neurodegenerative diseases
2017-02-17 BPM 31510-IV (ubidecarenone) gliosarcoma, recurrent glioblastoma 1-2 National Cancer Institute (NCI) BERG (USA - MA) Cancer - Oncology
2017-02-17 cabozantinib, nivolumab and ipilimumab urothelial cancer, bladder cancer, genitourinary cancer, urogenital neoplasms, urogenital cancer 1 National Cancer Institute (NCI) (USA) Cancer - Oncology
2017-02-16 selonsertib (GS-4997) NASH (non-alcoholic steatohepatitis) 3 Gilead Sciences (USA - CA) Hepatic diseases - Liver diseases